Among patients with advanced melanoma, sustained long-term overall survival at 5 years was observed in a greater percentage of patients who received nivolumab plus ipilimumab or nivolumab alone than in those who received ipilimumab alone.
https://cial20mg.online/ - cialis for sale in usa A total of 168 patients underwent randomization; 112 were assigned to the closed-loop group, and 56 were assigned to the control group.